Northwest Biotherapeutics IncAdd to My Watchlist

NWBO:USOTC USIndustry: Therapeutics
  • 0.24
    Last
  • 0.01  6.43%
    Today's Change
  • 0.23
    Previous Close
  • Today
     
    0.22
    1.84
    52 Week Low - High
8:10 pm ET 3/24/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding177 million
Market Cap$42 million
Return on Equity ttm--
Last DividendNWBO:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.807
EPS: Year Est. 12/16 ttm--
 
EPS: Quarterly Actual -- -0.27
EPS: Quarterly Est. -- --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate35.37
Company Description
Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.
Revenue$2 million
Net Income$-115 million
Total Assets$71 million
Employees12
Web Sitewww.nwbio.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!